JSM vs SRPT · P/E 16, $5.23B cap vs rev $1.13B
Navient Corporation SR NT 6% 121543 (JSM) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Navient Corporation SR NT 6% 121543 (JSM) is a other company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
JSM does not have a complete income-statement cache yet.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
JSM currently screens at market cap $5.23B and trailing P/E 15.9. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the JSM and SRPT stock pages for the full models.
Not investment advice.